Search for:
Search for:
Healthcare Professionals
Publications
News
EspaƱol
Contact
Magazine
Radio
Donate
Get Educated
What is MS?
A chronic neurological disorder that affects the central nervous system, comprised of the brain...
More Details
Educational Materials
Common Questions
Lending Library
Symptoms
Treatment Options
Additional Resources
Research
MS Awareness Month
Get Help
Health & Wellness Program
Get educational materials and referrals, as well as the opportunity to participate in various...
Learn More
Grants & Programs
Awareness Campaigns
Support Groups
Events
Lending Library
Additional Resources
Get Involved
MS Awareness Month
An annual, nationwide campaign with goals to promote an understanding of MS, and to assist those...
Learn More
Advocacy
Buy from Partners
Volunteer
Businesses
MS Research Trials
Outreach
Awareness Campaigns
Host an Event
Events
Test Flyout
lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem...
Learn More
Events Calendar
Health & Wellness
Fundraisers
Support
Web & Teleconferences
MS Education
Host an Event
About Us
Programs & Grants
More Details
Overview
Press Room
Leadership
Financial Statements
Our Mission
Careers at MS Focus
Affiliations
News & Features
Bengals vs Dolphins
The Miami Dolphins take on the Cincinnati Bengals and a portions of ticket sales will support the programs...
/Events/MSF-Events/2019/Third-Party-Events/Bengals-vs-Dolphins
Health and Wellness Grant
The MS Focus Health and Wellness Program offers adaptive exercise and wellness education in safe,...
/Get-Help/MSF-Programs-Grants/Health-and-Wellness-Program
Shop
Privacy
Terms of Use
Site Map
Targeting subset of T cells prevents, reverses MS in mice
October 07, 2019
A new study pinpoints the specific cells that cause demyelination in MS, as well as a protein on their surface that marks them. An antibody targeting the marked cells both prevented and reversed MS in a mouse model. If the findings bear out in human studies, targeting these rogue T cells could effectively treat MS, the researchers believe.
T helper cells in general have been known to drive MS, coordinating the attack on the protective myelin sheath that covers nerve fibers. Recent studies have pointed to TH17 cells. The new study by researchers at Boston Children's Hospital zeroed in on a subset of TH17-derived cells, all bearing the CXCR6 marker. These cells are fast-proliferating and very damaging, producing one set of proteins that directly damage cells and others, including GM-CSF, that stimulate an inflammatory attack by other immune cells known as macrophages.
The study showed that these cells also produce increased amounts of a protein called SerpinB1, and that this protein's presence is necessary for MS symptoms. When Sb1 was genetically deleted in T cells in the mouse MS model, fewer immune cells survived to infiltrate the spinal cord, and the disease was ameliorated as compared with control mice. The team then went on to show that these Sb1-containing cells could be readily identified with antibodies targeting the CXCR6 surface protein.
To investigate whether CXCR6-positive cells are relevant in human disease, the researchers worked with physicians in Boston Children's departments of Immunology and Neurology, as well as rheumatologists at Brigham and Women's Hospital, to obtain samples of synovial fluid from patients with inflammatory autoimmune arthritis. They found elevated levels of CXCR6+ cells in the inflamed joints. In contrast, circulating blood from the arthritis patients did not have elevated CXCR6+ cells. Nor did the blood of patients with MS or from healthy controls.
When the team used monoclonal antibodies to target CXCR6, the harmful cells largely disappeared, and mice, which were primed to get MS, did not develop the disease. Results of mouse model studies sometimes do not translate to humans and may be years away from being a marketable treatment. However, the researchers believe treatments to deplete CXCR6+ cells could mitigate MS and possibly other autoimmune disorders while largely leaving other T cell immune defenses intact.
The findings were published the journal
PNAS
.
MS Focus Lending Library
Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more
Study uncovers potential risks of common MS treatment
Study finds an increased risk of events such as stroke, migraine, and depression, and abnormalities in the blood with taking beta interferon for MS.
Learn more